Amedisys, Inc.

Equities

AMED

US0234361089

Healthcare Facilities & Services

Real-time Estimate Cboe BZX Other stock markets 02:46:57 2024-05-13 pm EDT			5-day change	1st Jan Change
95.18 ^USD	-0.34%		+3.23%	+0.27%

Apr. 24	Earnings Flash (AMED) AMEDISYS Reports Q1 EPS $1.03	MT
Apr. 24	Amedisys, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Amedisys, Inc. Announces Executive Changes

November 17, 2022 at 05:15 pm EST

The Board of Directors of Amedisys, Inc. announced that President and Chief Executive Officer, Chris Gerard, will leave the company effective November 17, 2022. Paul Kusserow, Chairman of the Board of Directors, will serve as Chairman and CEO until a replacement is hired. Paul served as the CEO of Amedisys for seven years until early 2022.

Amedisys announced that it will begin its executive search for a new CEO.

Latest news about Amedisys, Inc.

Earnings Flash (AMED) AMEDISYS Reports Q1 EPS $1.03	Apr. 24	MT
Amedisys, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 24	CI
UnitedHealth's Takeover of Amedisys Expected to Close Despite Potential Regulatory Hurdles, RBC Says	Mar. 25	MT
Amedisys Acquisition by UnitedHealth Unit Seen to Close Despite Potential DOJ Probe, RBC Says	Mar. 25	MT
RBC Raises Price Target on Amedisys to $100 From $97 to Reflect UnitedHealth Deal Terms, Keeps Outperform Rating	Mar. 25	MT
Oregon's health authority reviewing UnitedHealth's acquisition of Amedisys	Mar. 19	RE
UnitedHealth Faces Antitrust Probe in US	Feb. 28	MT
Earnings Flash (AMED) AMEDISYS Reports Q4 EPS $0.94	Feb. 21	MT
Amedisys, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 21	CI
Amedisys, Inc. Offers Advanced Molecular Testing to its Care Centers in Collaboration with Patient Choice Laboratories	Feb. 08	CI
Tranche Update on Amedisys, Inc.'s Equity Buyback Plan announced on February 9, 2023.	23-10-25	CI
Amedisys Q3 Adjusted Earnings, Net Service Revenue Decline	23-10-25	MT
Earnings Flash (AMED) AMEDISYS Posts Q3 EPS $0.98	23-10-24	MT
Amedisys, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-24	CI
Cantor Fitzgerald Adjusts Price Target on Amedisys to $101 From $100, Maintains Neutral Rating	23-09-14	MT
Amedisys, Inc. Announces Management Changes	23-08-30	CI
Deutsche Bank Adjusts Amedisys Price Target to $101 From $97, Maintains Buy Rating	23-07-31	MT
Option Care Health Q2 Earnings, Revenue Increase	23-07-27	MT
Tranche Update on Amedisys, Inc.'s Equity Buyback Plan announced on February 9, 2023.	23-07-27	CI
Earnings Flash (AMED) AMEDISYS Posts Q2 EPS $1.37	23-07-26	MT
Amedisys, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-26	CI
North American Morning Briefing : Focus Fixed on -2-	23-07-07	DJ
Jefferies Downgrades Amedisys to Hold From Buy, Adjusts Price Target to $101 From $98	23-07-06	MT
North American Morning Briefing : Claims Data, GDP -2-	23-06-29	DJ
North American Morning Briefing : Chip Stocks Take -2-	23-06-28	DJ

Chart Amedisys, Inc.

Duration

Period

More charts

Company Profile

Amedisys, Inc. is a healthcare service company. The Company is engaged in providing care and support in the home. It delivers clinically distinct care that suits its patients' needs, whether that is home-based recovery and rehabilitation after an operation or injury or care. Its operations involve serving patients across the United States through its three operating divisions: home health, hospice, and high acuity care. Its home health segment provides compassionate healthcare to help its patients recover from surgery or illness, live with chronic diseases, and prevent avoidable hospital readmissions. The home health includes 346 care centers located in 34 states within the United States and the District of Columbia. Its hospice care is designed to provide comfort and support for those who are dealing with a terminal illness. Its high acuity care segment delivers the essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes.

Sector

Healthcare Facilities & Services

Calendar

2024-07-30 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Amedisys, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

95.5 USD

Average target price

97.78 USD

Spread / Average Target

+2.39%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Home Healthcare Services

	1st Jan change	Capi.
AMEDISYS, INC.	+0.27%	3.12B
BRIGHTSPRING HEALTH SERVICES, INC.	0.00%	1.93B
ADDUS HOMECARE CORPORATION	+18.99%	1.77B
ENHABIT, INC.	-14.98%	418M
DOCGO INC.	-44.54%	307M
BASTIDE LE CONFORT MÉDICAL	-24.63%	161M
SAINT-CARE HOLDING CORPORATION	-13.04%	139M
KATO (HONG KONG) HOLDINGS LIMITED	+1.92%	67.83M

Home Healthcare Services